Home
Telix Pharmaceuticals TLX paid Hall, Render, Killian, Heath & Lyman, P.C. $13K for lobbying in Q3 2023 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $13,000
- Quarter
- Q3 2023
- Client
- Telix Pharmaceuticals US
- Reported
- 23/10/04
Up 52.9% from last quarter
What else happened in Telix Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/08/31~23/10/30Telix Pharmaceuticals US's other lobbying reports
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$40K
$40K
Reported 07/20
for Q2
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$50K
$50K
Reported 04/17
for Q1
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
Under $5,000
Under $5,000
Reported 04/07
for Q1
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$52K
$52K
Reported 01/20
for Q4 2025
- Telix Pharmaceuticals US
LobbyingTelix Pharmaceuticals
LobbyingTelix Pharmaceuticals
TLX
$13K
$13K
Reported 01/08
for Q4 2025